Studies showed that genetic variation in enzyme activity and decreased expression levels of PON-1 resulted in a decrease in enzyme efficiency to hydrolyze organophosphate insecticides, with consequent increase in toxicity and the risk for developing PD in exposed individuals (57-59). The gene discussed is PON1; the disease is Parkinson disease.